Article may be outdated

This article is 8 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
Nature·4 min read·hard

Plasma p-tau217 as a two-cutoff approach to improve tau-PET screening and trial recruitment in Alzheimer’s disease

A
Abtahi, Yasaman
Plasma p-tau217 as a two-cutoff approach to improve tau-PET screening and trial recruitment in Alzheimer’s disease
✦AI Summary

A study suggests that plasma p-tau217 is an effective blood-based biomarker for screening Alzheimer's disease and predicting tau-PET positivity. A two-cutoff diagnostic strategy helps reduce indeterminate results, potentially streamlining clinical trial recruitment.

Why it mattersUnlock →

Scientific Reports ( 2026 ) Cite this article

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in